ArticleBMJ open2021

Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity.

Mitsuru Arima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.